199 related articles for article (PubMed ID: 20363332)
1. Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture.
Hoffmann A; Müller MQ; Gloser M; Sinz A; Rudolph R; Pfeifer S
Protein Expr Purif; 2010 Aug; 72(2):238-43. PubMed ID: 20363332
[TBL] [Abstract][Full Text] [Related]
2. Production of bioactive, SUMO-modified, and native-like TNF-α of the rhesus monkey, Macaca mulatta, in Escherichia coli.
Jia D; Yang H; Wan L; Cheng J; Lu X
Appl Microbiol Biotechnol; 2012 Mar; 93(6):2345-55. PubMed ID: 22207214
[TBL] [Abstract][Full Text] [Related]
3. [Expression, purification and refolding of streptavidin-tagged human tumor necrosis factor-alpha fusion protein].
Xu CX; Hu ZM; Li JL; Gao JM
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):412-5. PubMed ID: 19304513
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
Boismenu R; Semeniuk D; Murgita RA
Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of recombinant human and murine TNF.
Curnis F; Corti A
Methods Mol Med; 2004; 98():9-22. PubMed ID: 15064429
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification of human PYY(3-36) in Escherichia coli using a His-tagged small ubiquitin-like modifier fusion.
Fazen CH; Kahkoska AR; Doyle RP
Protein Expr Purif; 2012 Sep; 85(1):51-9. PubMed ID: 22771863
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of human renalase1 in Escherichia coli and its purification as a FAD-containing holoprotein.
Pandini V; Ciriello F; Tedeschi G; Rossoni G; Zanetti G; Aliverti A
Protein Expr Purif; 2010 Aug; 72(2):244-53. PubMed ID: 20302943
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of an antitumor-analgesic peptide from the venom of Mesobuthus martensii Karsch by small ubiquitin-related modifier fusion in Escherichia coli.
Cao P; Yu J; Lu W; Cai X; Wang Z; Gu Z; Zhang J; Ye T; Wang M
Biotechnol Prog; 2010; 26(5):1240-4. PubMed ID: 20945481
[TBL] [Abstract][Full Text] [Related]
10. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
[TBL] [Abstract][Full Text] [Related]
11. Optimization of BLyS production and purification from Escherichia coli.
Laird MW; Sampey GC; Johnson K; Zukauskas D; Pierre J; Hong JS; Cooksey BA; Li Y; Galperina O; Karwoski JD; Burke RN
Protein Expr Purif; 2005 Feb; 39(2):237-46. PubMed ID: 15642475
[TBL] [Abstract][Full Text] [Related]
12. Influence of the protein oligomericity on final yield after affinity tag removal in purification of recombinant proteins.
Kenig M; Peternel S; Gaberc-Porekar V; Menart V
J Chromatogr A; 2006 Jan; 1101(1-2):293-306. PubMed ID: 16256128
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification and characterization of aprotinin and a human analogue of aprotinin.
Sun Z; Lu W; Jiang A; Chen J; Tang F; Liu JN
Protein Expr Purif; 2009 Jun; 65(2):238-43. PubMed ID: 19152836
[TBL] [Abstract][Full Text] [Related]
14. Production of recombinant peptides as fusions with SUMO.
Satakarni M; Curtis R
Protein Expr Purif; 2011 Aug; 78(2):113-9. PubMed ID: 21586326
[TBL] [Abstract][Full Text] [Related]
15. Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro.
Jonsson A; Wållberg H; Herne N; Ståhl S; Frejd FY
Biotechnol Appl Biochem; 2009 Aug; 54(2):93-103. PubMed ID: 19545237
[TBL] [Abstract][Full Text] [Related]
16. Expression and purification of soluble human APRIL in Escherichia coli using ELP-SUMO tag.
Zhang J; Ma L; Zhang SQ
Protein Expr Purif; 2014 Mar; 95():177-81. PubMed ID: 24412409
[TBL] [Abstract][Full Text] [Related]
17. Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography.
Tsukamoto H; Fukudome K; Kohara J; Nakatake H; Kimoto M
Protein Expr Purif; 2007 Nov; 56(1):138-44. PubMed ID: 17703948
[TBL] [Abstract][Full Text] [Related]
18. Expression and purification of the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARalpha).
Müller MQ; Roth C; Sträter N; Sinz A
Protein Expr Purif; 2008 Dec; 62(2):185-9. PubMed ID: 18755277
[TBL] [Abstract][Full Text] [Related]
19. High yield expression and single step purification of human thionein/metallothionein.
Hong S; Toyama M; Maret W; Murooka Y
Protein Expr Purif; 2001 Feb; 21(1):243-50. PubMed ID: 11162412
[TBL] [Abstract][Full Text] [Related]
20. Monitoring cleavage of fusion proteins by matrix-assisted laser desorption ionization/mass spectrometry: recombinant HIV-1IIIB p26.
Parker CE; Papac DI; Tomer KB
Anal Biochem; 1996 Jul; 239(1):25-34. PubMed ID: 8660621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
